New Zealand police are training drones on a legal marijuana farm, using artificial intelligence (AI) to identify illegal cannabis crops. The goal of the training is to see if marijuana can be “detected by a specialist camera system.” AI drones are commonly used by police for various operations.
“Police primarily use Remotely Piloted Aircraft Systems (RPAS), or drones, for crime scene and road crash photography, and quickly locating people in inaccessible places during search and rescue operations,” the spokesperson told Stuff. “All RPAS include AI features such as object recognition, object tracking, and obstacle avoidance to assist with their safe operation."
This is not the first time New Zealand cops have conducted aerial searches for illegal weed cultivation. It dropped the previous project in January 2021, because of a lack of interest from leaders of the 12 police districts. Now it is resuming the operation.
What About MMJ Patients Who Struggle To Afford Medicine?
According to Sarah Helm, executive director at the NZ Drug Foundation said the resumed practice might trouble individuals who consume marijuana for medical purposes from illegal sources, due to challenges in obtaining legal prescriptions.
“Patients are still largely having to use illicit cannabis because of the high cost and inaccessibility of medicinal cannabis through prescription ... so cannabis patients, I imagine, might feel quite scared hearing that news, scared for themselves about their ability to access essential medicine,” Helm said.
While medical marijuana can be prescribed for various conditions from chronic pain to epilepsy in New Zealand, it is not being funded by the Pharmaceutical Management Agency, better known as Pharmac. Per data from the Cannabis Clinic, the average cost for a two-month supply of medical marijuana products is between $200 to $300, which not something all medical marijuana patients can afford.
“I think that's also what drives that ‘let’s get it through non-official channels’ if I can put it that way, because at least you can get that at a more reasonable cost, but that, of course, has other issues associated with it,” said Marlborough district GP Roslan Gellatlys.
The news comes on the heels of the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) reclassifying low-dose CBD products allowing registered pharmacists to supply approved low-dose CBD medicines to “patients aged 18 years and older under certain conditions,” without prescription.
See Also: Global Cannabis: Montreal's Baby Boomers & Millennials Pot Use, South Africa As New Amsterdam & More
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.Don’t miss out on the green rush!
Photo: Courtesy of Karl Greif on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.